UA106870C2 - ANTIBODIES SPECIFIC TO PROTOFIBILLARY FORM OF BETA-AMYLOID PROTEIN - Google Patents

ANTIBODIES SPECIFIC TO PROTOFIBILLARY FORM OF BETA-AMYLOID PROTEIN

Info

Publication number
UA106870C2
UA106870C2 UAA201005859A UAA201005859A UA106870C2 UA 106870 C2 UA106870 C2 UA 106870C2 UA A201005859 A UAA201005859 A UA A201005859A UA A201005859 A UAA201005859 A UA A201005859A UA 106870 C2 UA106870 C2 UA 106870C2
Authority
UA
Ukraine
Prior art keywords
protofibillary
beta
antibodies specific
amyloid protein
amyloid peptide
Prior art date
Application number
UAA201005859A
Other languages
Ukrainian (uk)
Inventor
Джеффрі В. Равеч
Хідехіро Фукуяма
Original Assignee
Дзе Рокфеллер Юніверсіті
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Дзе Рокфеллер Юніверсіті filed Critical Дзе Рокфеллер Юніверсіті
Priority claimed from PCT/US2008/083659 external-priority patent/WO2009065054A2/en
Publication of UA106870C2 publication Critical patent/UA106870C2/en

Links

Abstract

Винахід належить до виділеного моноклонального антитіла, яке специфічно зв’язується з конформаційним епітопом протофібрилярної форми β-амілоїдного пептиду людини. Також винахід належить до способу визначення кількості протофібрилярної форми β-амілоїдного пептиду, набору для визначення протофібрилярної форми β-амілоїдного пептиду та фармацевтичної композиції, що містить протофібрилярну форму β-амілоїдного пептиду.The invention relates to a isolated monoclonal antibody that specifically binds to the conformational epitope of the protofibrillar form of human β-amyloid peptide. The invention also relates to a method for determining the amount of a protofibrillar form of a β-amyloid peptide, a kit for determining the protofibrillar form of a β-amyloid peptide, and a pharmaceutical composition comprising a protofibrillar form of β-amyloid peptide.

UAA201005859A 2007-11-16 2008-11-14 ANTIBODIES SPECIFIC TO PROTOFIBILLARY FORM OF BETA-AMYLOID PROTEIN UA106870C2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US98848107P 2007-11-16 2007-11-16
PCT/US2008/083659 WO2009065054A2 (en) 2007-11-16 2008-11-14 Antibodies specific for the protofibril form of beta-amyloid protein

Publications (1)

Publication Number Publication Date
UA106870C2 true UA106870C2 (en) 2014-10-27

Family

ID=56285166

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA201005859A UA106870C2 (en) 2007-11-16 2008-11-14 ANTIBODIES SPECIFIC TO PROTOFIBILLARY FORM OF BETA-AMYLOID PROTEIN

Country Status (1)

Country Link
UA (1) UA106870C2 (en)

Similar Documents

Publication Publication Date Title
CY1122458T1 (en) ANTI-N3PGLU AMYLOID BETA PEPTIDE ANTIBODIES AND USES THEREOF
CY1120951T1 (en) HUMAN ANTIBODIES ENANTI-TAU
UA109633C2 (en) HUMAN ANTIBODY AGAINST TISSUE FACTOR
CL2013002888A1 (en) Antibody that binds antigenic peptide that is obtained from a tau protein; pharmaceutical composition comprising; use to treat neurodegenerative disorder or disease; test kit, cell line (div 2457-2011).
EP2352523A4 (en) Improved anti-cd19 antibodies
UY32752A (en) Polypeptides and Treatment Methods
CL2012003245A1 (en) Isolated antigen binding protein that binds to thymic stromal lymphopoietin (tslp); A composition comprising an antigen-binding protein that binds tslp corresponding to a human anti-tslp antibody.
CL2008001742A1 (en) Monoclonal antibody that recognizes a conformational epitope and binds to polymeric soluble amyloid peptides and oligomeric amyloid peptides; polynucleotide that encodes it; composition that includes it; and its use to treat diseases associated with amyloid proteins.
BR112012006492A2 (en) multivalent antibody fusion protein, and albumin binding
EA201291181A1 (en) COMPOSITIONS AND METHODS OF APPLICATION OF THERAPEUTIC POLYVALENT ANTIBODIES AGAINST PROTEIN RELATED TO LOW DENSITY 6 LIPOPROTEIN RECEPTOR (LRP6)
UA113623C2 (en) TISSUE FACTOR FACTOR (TFPI) MONOCLONAL ANTIBODY AGAINST TISSUE FACTOR INHIBITOR
UA107574C2 (en) Humanized antibody specific to the protofibrillar form of the beta-amyloid peptide
EA201391159A1 (en) HLA-Restricted Peptidospecific Antigen Binding Proteins
AR067199A1 (en) PROTEINS OF UNION TO ANTIGENS THAT JOIN PAR-2
IN2014MN00873A (en)
CY1111409T1 (en) Monoclonal antibody and single-chain antibody fragments against cell membrane antigenic surface antigen
NO20071436L (en) Humanized Anti-5T4 Antibodies and Anti-5T4 Antibody / Calicheamicin Conjugates
NZ597023A (en) Monoclonal antibodies that bind to hGM-CSF and medical compositions comprising same
ES2639026T3 (en) Totally human antibodies specific for CADM1
IL212056A0 (en) Monoclonal antibodies and methods for their use in the detection of cervical disease
EA201000053A1 (en) NEW ANTIBODIES
UA117657C2 (en) ANTIBODY TO TRANSGLUTAMINASE 2 (TG2)
MX2013002718A (en) Anti-vegfr-3 antibody compositions.
GB0611708D0 (en) Novel antibodies against prion protein and uses thereof
MX2009008754A (en) Novel antibodies against igf-ir.